Catalyst Wire Dossier Catalyst Wire Dossier

GLARGEN®

insulin glargine · Les Laboratoires des Médicaments Stériles
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLARGEN®, covering 2025-05-31 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients. [Phase 4]

See pricing